PUNE, India, February 24, 2016 /PRNewswire/ --
The HPV testing and PaP test market growth is projected for the next 5 years to be driven by increasing awareness of cervical cancer screening programs, and government initiative and funding. The market is set to reach USD 4,523.1 Million by 2020 from 3,287.4 Million in 2015, at a CAGR of 6.6% from 2015 to 2020.
Complete report on global HPV testing and Pap test market spread across 124 pages, profiling 10 companies and supported with 80 tables and 52 figures is now available at http://www.rnrmarketresearch.com/hpv-testing-pap-test-market-by-test-type-hpv-testing-follow-up-co-testing-primary-by-application-pap-test-cervical-cancer-vaginal-cancer-by-end-user-laboratories-hospitals-physicians-offices-c-st-to-2020-market-report.html .
On the basis of test type, the HPV testing and Pap test market is divided into two major segments, namely, HPV testing and Pap test. The HPV testing segment is further classified into three sub-segments, namely, follow-up HPV testing, co-testing, HPV primary testing. The Pap test segment is expected to account for the largest share of the HPV testing and Pap test market in 2015. But this segment is projected to decline at a negative during the forecast period due to due the shift towards the use of HPV testing, as it provides enhanced accuracy and sensitivity than Pap test. Furthermore, the HPV testing segment is expected to grow at the highest CAGR in the next five years, owing to increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.
On the basis of the type of application, the global HPV testing and Pap test market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected to account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about cervical cancer screening.
On the basis of the type of end user, the HPV testing and Pap test market is classified into three segments, namely, hospitals, laboratories, physicians' offices and clinics. The laboratories end-user segment is expected to account for the largest share of the HPV testing and Pap test market in 2015. Furthermore, the hospitals end-user segment is expected to grow at the highest CAGR in the next five years, as most of the diagnostic tests are carried out in-house in hospitals with advanced technologies in a shorter period of time.
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and sub segments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market. The report also offers market sizes and data of the various segments in this industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives by governments. The competitive landscape covers the growth strategies adopted by industry players in the last three years.
Leading players have been profiled in this research such as Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Onco Health Corporation, Seegene, Inc., Femasys Inc. and Arbor Vita Corporation. Order a copy of HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians' Offices & Clinics) - Global Forecast to 2020 research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=479240 .
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
On a related note, another research on Hemostats Market Global Forecast to 2020 says, market size for hemostats is projected to reach USD 2.76 billion by 2020, at a CAGR of 6.2% during from 2015 to 2020. Increasing number of surgery procedures and increasing number of insurance providers to bear the high cost of these medical devices like hemostats products are the major factors influencing the growth of this market. Johnson & Johnson Services, Inc., C. R. Bard, Inc., Baxter, B Braun Melsungen AG, Pfizer Inc., Vascular Solutions, Inc., Gelita Medical GmbH, Equimedical, Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.) have been profiled in this 159 pages research report available at http://www.rnrmarketresearch.com/hemostats-market-by-product-type-thrombin-oxidised-regenerated-cellulose-combination-gelatin-collagen-and-geography-americas-europe-apac-mea-global-forecast-to-2020-market-report.html .
Explore more reports on Life Sciences market at http://www.rnrmarketresearch.com/reports/life-sciences .
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+/Google Plus: https://plus.google.com/104156468549256253075/posts
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
SOURCE RnR Market Research